PCLO.V - PharmaCielo Ltd.

TSXV - TSXV Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 5482.37M
Enterprise Value 3425.93M
Trailing P/E N/A
Forward P/E 145.55
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)9.28
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-13.21

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 32.59%
52 Week High 311.50
52 Week Low 34.02
50-Day Moving Average 35.13
200-Day Moving Average 37.13

Share Statistics

Avg Vol (3 month) 3135.13k
Avg Vol (10 day) 385.09k
Shares Outstanding 596.28M
Float 78.57M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Aug 30, 2019) 43.13M
Short Ratio (Aug 30, 2019) 422.27
Short % of Float (Aug 30, 2019) 4N/A
Short % of Shares Outstanding (Aug 30, 2019) 43.25%
Shares Short (prior month Jul 31, 2019) 42.94M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 211/1
Last Split Date 3Jan 18, 2019

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-36.64k
EBITDA -32.24M
Net Income Avi to Common (ttm)-36.51M
Diluted EPS (ttm)-0.42
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)33.46M
Total Cash Per Share (mrq)0.34
Total Debt (mrq)1.42M
Total Debt/Equity (mrq)2.73
Current Ratio (mrq)7.36
Book Value Per Share (mrq)0.54

Cash Flow Statement

Operating Cash Flow (ttm)-17.53M
Levered Free Cash Flow (ttm)N/A